More about Cellex-C and Clinical Research
More About More about Cellex-C and Clinical Research
CELLEX-C SKIN FIRMING CREAM HELPS REDUCE ROSACEA SYMPTOMS
A recent study examining the therapeutic effects of topical vitamin C on patients with acne rosacea revealed that Cellex-C’s patented ingredient complex proved beneficial to reducing skin’s redness from rosacea and improving skin tone.
Dr. R.B. Carlin, of Saddleback Memorial Hospital in Laguna Hills, California, utilized an adapted version of Cellex-C’s Skin Firming Cream containing the principal ingredient of 5% L-ascorbic acid, plus tyrosine and zinc on patients with Acne Rosacea -- a chronic, progressive inflammatory dermatosis of the face exacerbated by free radical production. The study’s premise was that vitamin C could prove to be an effective therapeutic agent for acne rosacea since vitamin C’s antioxidant properties have been shown to decrease UV-induced free radicals when applied topically and used systemically.
Twelve patients (7 women, 5 men) with stage 1 acne rosacea [facial erythema] and stage 2 acne rosacea [papules, postules and enlarged pores] applied Cellex-C Skin Firming Cream to one side of their face and a placebo to the other every morning. To parallel a real-world clinical situation, the patients were invited to continue applying their current topical medications at night (to avoid mixing them with the test products) and were encouraged to apply sunscreen and make-up in the morning after applying the test products. After three weeks, the patients reported any noticeable difference from four areas on each side of the face as well as observing degrees of redness.
The results revealed that Cellex-C Skin Firming Cream contributed to a marked reduction in the inflamed redness of rosacea and the rapid onset of therapeutic action in 9 of the 12 patients.
According to Dr. Carlin, “The topical vitamin C preparation tested in this study produced clinically and statistically significant results in reducing erythema within 3 weeks, even when added to patients’ existing rosacea and sunscreen use. In our judgement, this preparation is an efficacious, rapidly acting agent that can be added to other therapies to reduce erythema of acne rosacea.”
Moreover, Dr. Carlin concluded that Cellex-C’s patented formulation may well have a culminative effect that could surpass the effect of vitamin C administered alone, and that other products with higher vitamin C content and greater acidity may not yield the same results. Therefore, those Cellex-C products containing the same patented complex especially Skin Firming Cream Plus or Eye Contour Cream would be helpful for rosacea patients.